E-submission
Search
- Page Path
- HOME > Search
Newsletter
- What’s new in bone and soft tissue pathology 2023: guidelines for molecular testing
- Farres Obeidin
- J Pathol Transl Med. 2023;57(3):184-187. Published online April 5, 2023
- DOI: https://doi.org/10.4132/jptm.2023.03.20
- 9,484 View
- 544 Download
- 2 Web of Science
- 3 Crossref
-
Abstract
PDF - Our understanding of bone and soft tissue tumors has thoroughly evolved as a consequence of modern molecular techniques. DNA and RNA sequencing methods play an important diagnostic and therapeutic role in sarcoma pathology. Herein, we discuss current guidelines and best practices for molecular testing in bone and soft tissue tumors.
-
Citations
Citations to this article as recorded by
- Pathology of soft tissue tumours
Runjan Chetty
Surgery (Oxford).2026; 44(2): 67. CrossRef - Next-Generation Sequencing Refines Diagnosis and Expands Precision Medicine Opportunities in Soft Tissue Sarcomas
Francine Tesser-Gamba, Thais Biude Mendes, Fernanda Teresa Lima, Simone de Campos Vieira Abib, Eliana Maria Monteiro Caran, Silvia Regina Caminada de Toledo
International Journal of Molecular Sciences.2026; 27(16): 7201. CrossRef -
RB1: governor of the cell cycle in health and disease—a primer for the practising pathologist
Fleur Cordier, David Creytens
Journal of Clinical Pathology.2024; 77(7): 435. CrossRef
- Pathology of soft tissue tumours
First
Prev
